Replies to post #235605 on Biotech Values

[bladerunner1717]

MYOV up almost 7% in AH trading on the coattails of the UROV acquisition. Sumitomo owns a high percentage of MYOV shares.


Bladerunner

[DewDiligence]

UROV minority_shareholders_approve_cash_buyout_by parent_company, Sumitovant Biopharma:

https://www.sec.gov/Archives/edgar/data/1740547/000119312521092665/d73533d8k.htm

The deal should close in the next few days.